- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Small Cell Lung Cancer in Canada
Total 1507 results
-
MedImmune LLCTerminatedNon-small Cell Lung CancerUnited States, Canada, Japan, Poland, Germany, Hungary, France
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerFrance, Spain, United States, Belgium, Netherlands, Canada, Italy, Singapore, Korea, Republic of, Czechia, Germany, Hong Kong
-
Ottawa Regional Cancer CentreUnknown
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerCanada
-
Fundación GECPRecruitingNon Small Cell Lung Cancer | EGFR Gene MutationSpain
-
Centre hospitalier de l'Université de Montréal...Active, not recruitingNon Small Cell Lung Cancer Metastatic | Advanced MelanomaCanada
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
Geron CorporationCompletedNon-small Cell Lung CancerUnited States, Canada, Germany
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, Belgium, France, Italy, Netherlands, Canada, United Kingdom, United States
-
Fundación GECPCompletedNon Small Cell Lung CancerSpain
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
Fundación GECPCompletedMetastatic Non Small Cell Lung CancerSpain
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Canada, France, Singapore, Taiwan
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Concordia Laboratories Inc.CompletedNon-small Cell Lung Cancer (NSCLC) | Lung MetastasisUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbActive, not recruitingNon-Small Cell Lung CancerUnited States, Canada
-
Genentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, France, Serbia
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
Hoffmann-La RocheRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Canada, Turkey, Brazil, Spain, France, Germany, Australia, Italy, Belgium, Mexico
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingNon-small Cell Lung CancerUnited States, New Zealand, Australia, Costa Rica, Taiwan, Argentina, France, Chile, Hungary, Spain, Greece, Poland, Canada, Lithuania, Norway, Italy, Czechia
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Lawson Health Research InstituteActive, not recruiting
-
Dizal PharmaceuticalsRecruitingNon-small Cell Lung CancerChina, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, Turkey
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
-
Spanish Lung Cancer GroupTerminatedNon Small Cell Lung Cancer | BRCA1 MutationSpain
-
AstraZenecaCompletedNon Small Cell Lung CancerUnited States, Belgium, France, Italy, Spain, Canada, Brazil, Hungary, Peru, Czechia, Bulgaria, Mexico
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Immunotec Inc.TerminatedNON-SMALL CELL LUNG CANCERCanada
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Turnstone Biologics, Corp.CompletedNon-Small Cell Lung CancerCanada
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerCanada, United States, Spain, Italy, France
-
Janssen Research & Development, LLCActive, not recruitingNon-Small-Cell Lung CancerUnited States, France, Taiwan, United Kingdom, China, Spain, Japan, Australia, Korea, Republic of, Canada
-
Astex Pharmaceuticals, Inc.CompletedNon-small Cell Lung Cancer(NSCLC)United States, Korea, Republic of, Spain, France, Canada
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerIndia, Turkey, China, United States, Germany, Spain, Taiwan, Belgium, Korea, Republic of, France, Greece, Netherlands, United Kingdom, Australia, Canada, Brazil, Ireland, Portugal, Argentina
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerUnited States, Spain, China, France, Canada, Italy
-
AstraZenecaParexelRecruitingNon-small Cell Lung CancerHungary, United States, Italy, Belgium, Spain, France, Korea, Republic of, Taiwan, Turkey, Ireland, Portugal, Canada
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNSCLC | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | TNBC - Triple-Negative Breast Cancer | NSCLC Stage IV Without EGFR/ALK MutationUnited States, Canada
-
Merck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Argentina, Australia, Belgium, Brazil, Canada, China, Estonia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Poland, Romania, Russian Federation, South Africa, Spain, Taiwan, U... and more